iodine and su 11248

iodine has been researched along with su 11248 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beck-Peccoz, P; Bertuelli, R; Carletto, M; Casali, PG; Coco, P; Fugazzola, L; Mannavola, D; Vannucchi, G1
Bauman, JE; Capell, PT; Carr, LL; Eaton, KD; Goulart, BH; Kell, EM; Mankoff, DA; Martins, RG1
Casuscelli, J; Graser, A; Hellbach, K; Hummel, N; Ingrisch, M; Karpitschka, M; Schlemmer, M; Sommer, W; Staehler, M; Sterzik, A1
Adriaansz, S; Beijnen, JH; Blank, CU; Huitema, AD; Lankheet, NA; Mallo, H; Rosing, H; Schellens, JH1
Adriaansz, S; Beijnen, JH; Blank, CU; Haanen, JB; Huitema, AD; Lankheet, NA; Mallo, H; Schellens, JH1

Trials

3 trial(s) available for iodine and su 11248

ArticleYear
A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake.
    The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:9

    Topics: Adult; Aged; Biological Transport; Female; Gastrointestinal Stromal Tumors; Humans; Hypothyroidism; Indoles; Iodine; Iodine Radioisotopes; Male; Middle Aged; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Thyrotropin

2007
Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Nov-01, Volume: 16, Issue:21

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma; Carcinoma, Medullary; Cell Differentiation; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Indoles; Iodine; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Pyrroles; Sunitinib; Thyroid Neoplasms; Tomography, Emission-Computed; Treatment Failure

2010
The effect of seasonal variation and secretion of sunitinib in sweat on the development of hand-foot syndrome.
    European journal of clinical pharmacology, 2013, Volume: 69, Issue:12

    Topics: Aged; Antineoplastic Agents; Female; Hand-Foot Syndrome; Humans; Indoles; Male; Middle Aged; Pyrroles; Seasons; Sunitinib; Sweat

2013

Other Studies

2 other study(ies) available for iodine and su 11248

ArticleYear
Dual energy CT allows for improved characterization of response to antiangiogenic treatment in patients with metastatic renal cell cancer.
    European radiology, 2017, Volume: 27, Issue:6

    Topics: Aged; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Contrast Media; Female; Humans; Indoles; Iodine; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Prospective Studies; Protein-Tyrosine Kinases; Pyrroles; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome

2017
Determination of sunitinib and its active metabolite N-desethylsunitinib in sweat of a patient.
    Journal of analytical toxicology, 2011, Volume: 35, Issue:8

    Topics: Administration, Oral; Aged; Antineoplastic Agents; Biotransformation; Calibration; Carcinoma, Renal Cell; Chromatography, High Pressure Liquid; Dealkylation; Drug Administration Schedule; Female; Hand-Foot Syndrome; Humans; Indoles; Kidney Neoplasms; Limit of Detection; Protein Kinase Inhibitors; Pyrroles; Reproducibility of Results; Sunitinib; Sweat; Tandem Mass Spectrometry

2011
chemdatabank.com